國立虎尾科技大學 |

CNS drug development and delivery = concepts and applications /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	CNS drug development and delivery/ edited by Alan Talevi.
其他題名:	concepts and applications /
其他作者:	Talevi, Alan.
出版者:	Cham :Springer Nature Switzerland : : 2024.,
面頁冊數:	vii, 230 p. :ill. (some col.), digital ; : 24 cm.;
Contained By:	Springer Nature eBook
標題:	Pharmaceutics. -
電子資源:	https://doi.org/10.1007/978-3-031-62604-3
ISBN:	9783031626043

CNS drug development and delivery = concepts and applications /
CNS drug development and deliveryconcepts and applications /[electronic resource] :edited by Alan Talevi. - Cham :Springer Nature Switzerland :2024. - vii, 230 p. :ill. (some col.), digital ;24 cm. - AAPS introductions in the pharmaceutical sciences,v. 99992522-8358 ;. - AAPS introductions in the pharmaceutical sciences ;v. 13..

Chapter 1- Transporter-mediated drug delivery to the brain -- Chapter 2 - Mechanisms and methods for evaluating drug delivery via transcytosis to the brain -- Chapter 3 -In vitro blood-brain studies -- Chapter 4 - In silico prediction of CNS bioavailability -- Chapter 5 - Use of unbound exposure data to establish in vitro-in vivo correlations for CNS drug candidates -- Chapter 6 - Intranasal Delivery of Drugs to the Central Nervous System -- Chapter 7 - Polymeric nanoparticles for nose-to-brain delivery in Alzheimer's and Parkinson's diseases -- Chapter 8 - Barriers of the CNS and their contribution to drug-resistant epilepsy -- Chapter 9 - Network-pharmacology and central nervous system drug development.

The book covers recent advances in the field of CNS therapeutics, including opportunities posed by expanding basic knowledge related to CNS conditions and novel approaches for efficient drug delivery to the brain (e.g., pharmaceutical nanocarriers and transporter- and transcytosis-mediated drug delivery to the brain inhibition of the blood-brain barrier) Chapters dealing with state-of-the-art in silico and in vitro tools for predictive purposes related to CNS bioavailability are also be included. This is an ideal book for undergraduate students and graduates in the field of medicine and pharmaceutics, and professionals working in the field of brain disorders.

ISBN: 9783031626043

Standard No.: 10.1007/978-3-031-62604-3doiSubjects--Topical Terms:

1366841
Pharmaceutics.

LC Class. No.: RC361

Dewey Class. No.: 615.78

CNS drug development and delivery = concepts and applications /
LDR:02519nam a2200361 a 4500 001 1133555
003 DE-He213
005 20240713130857.0
006 m d
007 cr nn 008maaau
008 241213s2024 sz s 0 eng d
020 $a 9783031626043 $q (electronic bk.)
020 $a 9783031626036 $q (paper)
024 7 $a 10.1007/978-3-031-62604-3 $2 doi
035 $a 978-3-031-62604-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RC361
072 7 $a MMG $2 bicssc
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
072 7 $a MKG $2 thema
082 0 4 $a 615.78 $2 23
090 $a RC361 $b .C651 2024
245 0 0 $a CNS drug development and delivery $h [electronic resource] : $b concepts and applications / $c edited by Alan Talevi.
260 $a Cham : $c 2024. $b Springer Nature Switzerland : $b Imprint: Springer,
300 $a vii, 230 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a AAPS introductions in the pharmaceutical sciences, $x 2522-8358 ; $v v. 9999
505 0 $a Chapter 1- Transporter-mediated drug delivery to the brain -- Chapter 2 - Mechanisms and methods for evaluating drug delivery via transcytosis to the brain -- Chapter 3 -In vitro blood-brain studies -- Chapter 4 - In silico prediction of CNS bioavailability -- Chapter 5 - Use of unbound exposure data to establish in vitro-in vivo correlations for CNS drug candidates -- Chapter 6 - Intranasal Delivery of Drugs to the Central Nervous System -- Chapter 7 - Polymeric nanoparticles for nose-to-brain delivery in Alzheimer's and Parkinson's diseases -- Chapter 8 - Barriers of the CNS and their contribution to drug-resistant epilepsy -- Chapter 9 - Network-pharmacology and central nervous system drug development.
520 $a The book covers recent advances in the field of CNS therapeutics, including opportunities posed by expanding basic knowledge related to CNS conditions and novel approaches for efficient drug delivery to the brain (e.g., pharmaceutical nanocarriers and transporter- and transcytosis-mediated drug delivery to the brain inhibition of the blood-brain barrier) Chapters dealing with state-of-the-art in silico and in vitro tools for predictive purposes related to CNS bioavailability are also be included. This is an ideal book for undergraduate students and graduates in the field of medicine and pharmaceutics, and professionals working in the field of brain disorders.
650 2 4 $a Pharmaceutics. $3 1366841
650 2 4 $a Drug Delivery. $3 1366630
650 2 4 $a Neuropharmacology. $3 677629
650 1 4 $a Pharmacology. $3 583819
650 0 $a Drug delivery systems. $3 581921
650 0 $a Neuropsychopharmacology. $3 645314
650 0 $a Central nervous system $x Chemotherapy. $3 1454788
700 1 $a Talevi, Alan. $3 1211023
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
830 0 $a AAPS introductions in the pharmaceutical sciences ; $v v. 13. $3 1416732
856 4 0 $u https://doi.org/10.1007/978-3-031-62604-3
950 $a Biomedical and Life Sciences (SpringerNature-11642)